Nanomicelles co-loaded with doxorubicin and salvianolic acid A for breast cancer chemotherapy

Background: Multi-drug delivery system based on polymer carrier is emerging for alleviating dose-limiting toxicities of first-line cytotoxic anticancer drugs, such as doxorubicin (DOX) for breast cancer chemotherapy. By co-loading the premium natural antioxidant salvianolic acid A (SAA) through coll...

Full description

Bibliographic Details
Main Authors: Li, Y. (Author), Li, Z. (Author), Liu, J. (Author), Sun, Z. (Author), Wang, H. (Author), Xu, H. (Author), Yu, B. (Author), Zhao, F. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher